Veracyte (VCYT) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. VRNS
10. RXRX

Go back to Veracyte (VCYT) Misses Q2 EPS by 4c

Veracyte Announces Second Quarter 2015 Financial Results

August 13, 2015 4:05 PM EDT

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2015 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the second quarter ended June 30, 2015 and provided an update on recent business progress. For the second quarter of 2015, revenue was $11.9 million, an increase of 37%, compared to $8.7 million for the second quarter of 2014. Afirma® Gene Expression Classifier (GEC) volume increased to 4,758 tests, an increase of 38%, compared to the same period in 2014, bringing first-half 2015 GEC volume to 8,778 tests.

"We continue to see strong growth of Afirma... More